{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:57Z","timestamp":1786119537011,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/mjt.0b013e3181d7e1d3","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T02:52:03Z","timestamp":1273546323000},"page":"375-381","source":"Crossref","is-referenced-by-count":17,"title":["Parenteral Bisphosphonates for Osteoporosis in Patients With Primary Biliary Cirrhosis"],"prefix":"10.1097","volume":"18","author":[{"given":"Sombat","family":"Treeprasertsuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina G","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L","family":"Petz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol"},{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in primary biliary cirrhosis revisited.","volume":"49","author":"Newton","year":"2001","journal-title":"Gut"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","article-title":"Bone disorders in chronic liver disease.","volume":"46","author":"Collier","year":"2007","journal-title":"Hepatology"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/lt.20160","article-title":"Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism.","volume":"10","author":"Guichelaar","year":"2004","journal-title":"Liver Transpl"},{"key":"R6-8-20210202","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00774-007-0833-1","article-title":"Primary biliary cirrhosis and osteoporosis: a case-control study.","volume":"26","author":"Mounach","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.mcg.0000248017.31386.39","article-title":"Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.","volume":"42","author":"Benetti","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long-term follow-up and predictive factors.","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"R10-8-20210202","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.","volume":"98","author":"Guanabens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"AGA technical review on osteoporosis in hepatic disorders.","volume":"125","author":"Leslie","year":"2003","journal-title":"Gastroenterology"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/lt.500040508","article-title":"Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.","volume":"4","author":"Reeves","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.dld.2007.02.005","article-title":"A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.","volume":"39","author":"Floreani","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001980050132","article-title":"Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.","volume":"9","author":"Ringe","year":"1999","journal-title":"Osteoporos Int"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","article-title":"Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.","volume":"46","author":"Guichelaar","year":"2007","journal-title":"Hepatology"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","article-title":"A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.","volume":"29","author":"Pazianas","year":"2007","journal-title":"Clin Ther"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.clinthera.2005.04.005","article-title":"Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.","volume":"27","author":"Miller","year":"2005","journal-title":"Clin Ther"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cgh.2007.05.016","article-title":"A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.","volume":"5","author":"Abitbol","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-8-20210202","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10620-006-8015-x","article-title":"Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen\/progestin.","volume":"51","author":"Boone","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","article-title":"Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.","volume":"25","author":"Levy","year":"2005","journal-title":"Liver Int"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","article-title":"An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis.","volume":"256","author":"Ormarsdottir","year":"2004","journal-title":"J Intern Med"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0168-8278(00)80118-X","article-title":"Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial.","volume":"33","author":"Lindor","year":"2000","journal-title":"J Hepatol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181d7e1d3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:22Z","timestamp":1786040602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201109000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181d7e1d3","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}